NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

A business journalist who famously ditched her husband and job for disgraced “Pharma Bro” Martin Shkreli defended New York ...

Some drugmakers' submission of multiple "use codes" to expand patent claims appears to be delaying the arrival of lower-cost ...

Seattle-based biotech company Athira Pharma is laying off 49 people, or about 70% of its workforce, as part of ...

A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

Fierce Pharma’s Andrea Park and Ben Adams talk about major trends from the event that came up in conversations, including the ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

This week, a closer look at two commercials — one for and one against Democratic Senator Jacky Rosen pertaining to ...

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...